🇺🇸 FDA

Company profile · Sponsor

Recordati

Recordati Rare Diseases Australia Pty.

E51ECFD · TGA pharma Puteaux, AU
Pipeline
0
Drugs
4
Patents
0

Quick answer

Recordati (E51ECFD) is a pharma company. headquartered in Puteaux, AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 4 drugs, and 0 patents to this profile..

Company facts

Ticker E51ECFD
Exchange TGA
Company type pharma
Headquarters Puteaux, AU

Pipeline (0)

No pipeline programs linked yet.

Drugs (4)

Search drugs →

  1. betaine

    CYSTADANE

    ORAL approved

  2. osilodrostat

    ISTURISA

    H02CA02

  3. pasireotide embonate

    SIGNIFOR LAR

  4. siltuximab

    SYLVANT

    INJECTION approved

    L04AC11

Frequently asked questions

What is Recordati?

Recordati (E51ECFD) is a pharma company. headquartered in Puteaux, AU. listed on TGA. NovaPharmaNews links 0 pipeline programs, 4 drugs, and 0 patents to this profile..

Does Recordati have pipeline programs in our database?

No pipeline programs are currently linked to Recordati. Programs may be added as ClinicalTrials.gov sponsor matching improves — check back or search the global pipeline directory.

Where does Recordati company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.